BIOMAT Database Logo BIOMAT Database Logo

[Drug information. Agents for the treatment of diabetes mellitus (antidiabetics). Therapeutic main group: oral antidiabetics. 2. Sulfonylurea compounds]. 1977

I B Lumholtz

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

I B Lumholtz
[Treatment of diabetes mellitus with oral antidiabetics].
August 1967, Therapeutische Umschau. Revue therapeutique,
I B Lumholtz
[Treatment of diabetes mellitus with oral antidiabetics].
November 1976, Schweizerische medizinische Wochenschrift,
I B Lumholtz
[Treatment of diabetes mellitus with oral antidiabetics].
September 1957, Nederlands tijdschrift voor geneeskunde,
I B Lumholtz
[Ambulatory treatment of diabetes mellitus: oral antidiabetics].
November 1958, Revista brasileira de medicina,
I B Lumholtz
[Oral antidiabetics in the treatment of diabetes mellitus].
February 1960, Revue medicale de Liege,
I B Lumholtz
[Clinical use of oral antidiabetics from the sulfonylurea group].
July 1958, Arztliche Wochenschrift,
I B Lumholtz
Clinical use of oral sulfonylurea compounds in diabetes mellitus.
January 1957, Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School,
I B Lumholtz
Treatment of chemical diabetes mellitus with sulfonylurea compounds.
February 1973, Metabolism: clinical and experimental,
I B Lumholtz
[Modern treatment of diabetes mellitus with sulfonylurea compounds].
May 1979, Zeitschrift fur arztliche Fortbildung,
I B Lumholtz
Ruthenium compounds as potential therapeutic agents for type 2 diabetes mellitus.
March 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!